FELICIA MEILA: Open Payments
NPI 1720049802 · PAWTUCKET, RI. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$304 in 15 payments from 10 companies in 2025. Trend: 2023 $322 · 2024 $378 · 2025 $304
Food & beverage: $304
| Company | Payments | Amount |
|---|---|---|
| PFIZER INC. | 3 | $59 |
| ABBVIE INC. | 2 | $45 |
| Amgen Inc. | 2 | $43 |
| GlaxoSmithKline, LLC. | 2 | $42 |
| Novo Nordisk Inc | 1 | $27 |
| AstraZeneca Pharmaceuticals LP | 1 | $23 |
| Antares Pharma, Inc. | 1 | $21 |
| Exact Sciences Corporation | 1 | $16 |
| Lilly USA, LLC | 1 | $16 |
| Abbott Laboratories | 1 | $13 |
Products named: NURTEC ODT, Wegovy, OTEZLA, FARXIGA, SYNTHROID, QULIPTA, SHINGRIX, ELIQUIS.
Industry payments across RI — which companies pay providers there.
